The expression status of CLU might change in many human cancers, such as gastric cancer[22], colon cancer[23], pancreatic cancer, prostate cancer[24], breast cancer[25], lung cancer and renal cell carcinoma[26]. This evidence concerns the gene CLU and prostate cancer.